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INTRODUCTION
The number of patients with End Stage Renal Disease (ESRD) and total cost of ESRD care in the
United States have been increasing over the past decade. Inpatient hospital care accounts for
41% of ESRD cost (1), and has been the target of study whereby determining the underlying
primary cause of admission and attempting to prevent unnecessary hospitalization. In
comparison to the general population, patients on chronic dialysis have increased morbidity,
primarily from cardiovascular and infectious causes (2). Certain forms of morbidity, for
example those resulting from complications of dialysis or from dialysis vascular access
complications, are unique to the dialysis populations and are the frequent cause of hospitalization
(3-6). Several studies have used hospitalization as an index of morbidity and have established a
relationship of hospital utilization to referral pattern, anemia, diabetes, ischemic heart disease
(IHD) and temporary vascular access placement during ESRD (2, 6-31).
In a preliminary report, we studied rate, causes and outcomes of hospitalizations in hemodialysis
patients with and without diabetes mellitus, during the year elapsed between 2001 and 2002 (32).
The main findings of this small study was that the frequency and, marginally, the annual duration
of hospitalizations were greater in the patients with diabetes mellitus than non-diabetics and that
the two major causes of hospitalization, in terms of both frequency and duration, were
complications of dialysis vascular access and complications of severe peripheral vascular disease
in the lower extremities, rather than cardiac causes, which are reported as the major cause of
hospitalization nationally (2). Mix and colleagues reported similar findings in which diabetics
showed trends for greater hospitalization rates with regard to infectious disease compared to
causes from congestive heart failure (28). However, the differences in our preliminary study
could be caused by the relatively small number of patients, brief observation period, by
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population differences (veterans on dialysis at the New Mexico VAHCS are almost exclusively
male, elderly, often of low economic status, and have a frequency of diabetes mellitus that is
higher than the frequency reported in the national registry), or by differences in overall medical
care.

We therefore conducted a retrospective analysis of veterans who have been on chronic dialysis
for at least 6 months at the New Mexico VAHCS and observed trends in hospitalizations over an
11 year span. Our aims were to determine 1) whether a substantial fraction of hospitalizations in
patients on chronic hemodialysis are the results of potentially preventable conditions; 2) whether
the pattern of hospitalizations of veterans dialyzed at the New Mexico VAHCS is characterized
by a predominance of dialysis vascular access complications and severe peripheral vascular
disease events rather than by cardiovascular problems; and 3) whether there are qualitative and
quantitative differences in hospitalization patterns between those with and those without diabetes
mellitus.
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METHODS

Data were obtained from the electronic medical records at the New Mexico Veterans Affairs
Health Care System (VAHCS). Clinical information including date of birth, gender, presence or
absence of diabetes, date of onset of follow-up in the VA computer, date of onset of
hemodialysis, dates of admission, cause of admission, surgical interventions, outcome (discharge
from survival versus death) and last day of follow-up while on dialysis were obtained from the
discharge summaries and electronic records.

The study population was composed of veterans with ESRD who have been on chronic dialysis,
hemodialysis or peritoneal dialysis, for at least 6 months at the New Mexico VAHCS between
January 1, 1995 and June 30, 2005. We selected patients during this time period secondary to
the VAHCS maintaining computerized discharge summary records dating back to 1995.
Subjects were divided into two groups based on the co-morbidity of diabetes. Patients were
characterized as having diabetes as co-morbidity if they had: 1) diabetes as the primary cause of
ESRD or 2) have diabetes as a pre-existing condition despite whether cause of renal failure was
due to another etiology. Overall and cause specific hospitalization and impatient days were
determined for each patient and group. Hospitalization (inpatient) days were calculated as
number of hospital days in each admission. Outpatient visits and hospital visits <24 hours were
excluded from data set.

Reason for hospitalization was ascertained from the discharge summary and designated
appropriate principal diagnosis codes from the International Classification of Diseases, Ninth
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Revision, Clinical Modification (ICD-9-CM). Principal diagnoses were then classified into
broad categories and restricted to those deemed most likely to be impacted on by complications
of chronic kidney disease. Categories included one of the following: 1) cardiovascular; 2)
dialysis access-related; 3) infection unrelated to dialysis access; 4) other, 5) peripheral vascular
disease complications.
The study period for each patient was defined by the scope of availability of hospital discharge
summaries. These included all hospitalizations during the period January 1st 1995 to June 30th
2005.
All pertinent information was collected in an electronic (EXCEL) spread sheet that was created
in the VA computer located in the office of the principal investigator. The electronic spreadsheet
containing the data that was analyzed was maintained in the principal investigator’s VA
computer and contained only a code number for each patient with no way to identify individuals
in this spreadsheet. The principal investigator also maintained, in a secured place (locked drawer
in his VA office), a hand-written list without a title of code numbers (the first letter of the last
name and the last four digits of the social security number) of each patient that allowed direct
linkage of this list to the electronic spreadsheet.
Univariate comparisons for continuous variables will be carried out using parametric (paired on
non-paired t-test) and nonparametric (Wilkoxon sign rank test) depending on whether the
distribution of the data is normal or not. Univariate comparison of categorical variables will be
done by chi-square or Fisher’s exact test.
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RESULTS
Patient Population
Two hundred and forty four patients enrolled in the study, of which 146 were diabetic
and 146 were non-diabetic. The mean age was comparable between diabetics and non-diabetics
(63 and 64 years of age, respectively), with more than half the cohort (59%) having diabetes.
Number of women in both groups, non-diabetic and diabetic, was comparable (N=4, N=6;
respectively) and a small percentage in perspective to the study population.

Overall Hospitalizations and Inpatient Day Rates
Total number of hospital admissions amongst the cohort was 1473. Table 1 lists patient
characteristics, overall hospitalization admissions, and inpatient day rates. Number of
hospitalizations from all causes was 602 in the non-diabetic patients and 871 in those with
diabetes. Total number of hospitalization days and inpatient day rates, defined as number of
hospital days per number of admissions, were highest in diabetics (9595, 10.99; respectively)
compared with non-diabetics (5326, 8.85; respectively).

Cause Specific Admissions, Hospitalization Days and Inpatient Rates
Table 2 lists cause specific hospitalization days and inpatient day rates. Subjects with
diabetes exhibited increased number of hospital admissions in each group compared with those
without diabetes. Figure 2 illustrates the number of admissions per group in non-diabetics and
diabetics. Amongst cause specific etiologies related to duration in the hospital, quantified in
days, non-diabetics were highest for infectious disease related causes (N=2677 days) and for
other causes (N=3569 days) not attributable to other respective groups, this pattern was also
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exhibited for the diabetic population (N=2526, and 1225 days respectively). Figure 3 graphically
illustrates the number of hospital days per group in the two respective populations. Conversely,
inpatient day rates were highest amongst infectious disease causes in both non-diabetics
(N=9.65) and diabetics (N=13.52) followed by other causes in non-diabetics (N=10.48) and
peripheral vascular disease causes in diabetics (N=15.07). There was a statistically significant
difference in the diabetic population compared with non-diabetics amongst cause specific
hospitalizations in the cardiovascular disease group (p<0.05), dialysis vascular access group
(p<0.05) and peripheral vascular disease group (p<0.001). No difference existed in the
infectious disease group and complications attributable to other etiologies. Table 3 summarizes
cause specific number of hospitalizations in non-diabetics and diabetics.
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DISCUSSION

Hospitalization during end stage renal disease (ESRD) has not been thoroughly evaluated as a
function of existing co-morbidities such as the presence and absence of diabetes, and factors
associated with hospitalizations have been poorly evaluated (33-35). The current study,
composed of patient records spanning 11 years, provides new information regarding the pattern,
frequency and duration of hospital stay in patients with ESRD. Previous studies have shown
increased hospitalization rates in patients with ESRD and the co-morbidity of diabetes (1,15,28).
Total number of hospitalizations in our study was 1472, with the diabetic population having
increased proportion of hospitalizations (60%). This supports the notion of diabetes acting as a
risk factor for hospital utilization and replicates similar findings in our preliminary study in
which annual duration of hospitalizations were greater in the patients with diabetes mellitus than
non-diabetics.

Cause specific duration of hospital stay and number of admissions was greater in all groups in
those with diabetes compared with non-diabetics, the infectious disease group being the
prominent factor. This is contrary to previous studies in which dialysis vascular access
complications and cardiovascular complications are the majority of cause specific
hospitalizations (3-6). Our study supports that dialysis access related complications represents a
substantial proportion of inpatient hospital stay but not to the extent of 25 to 31% documented in
previous studies (1,3,28,33). Furthermore, previous studies have exhibited cardiovascular causes
as a leading cause of hospitalization amongst ESRD patients receiving dialysis (1-4, 28,33,36).
However, no statistical difference was observed in frequency of hospitalization in the infectious
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disease group. Along these lines, if we eliminate causes of inpatient presentation unrelated to
ESRD, cardiovascular etiologies and peripheral vascular disease complications are the second
and third leading cause of frequency of hospitalization in both diabetic and non-diabetic
populations, respectively, both statistically greater in the diabetic population. This is consistent
with the literature in which diabetics had more frequent and more prolonged hospitalizations
than non-diabetics.

Mean days per admission were higher in the population with diabetes in the infectious disease
and peripheral vascular disease groups. This finding confirms the findings of studies which
show increased hospitalization rates related to infectious disease in diabetics (28,33). Our study
demonstrates that ESRD patients with diabetes suffer increased days for resolution of ailments.
Given the pathophysiology of diabetes and complications such as decreased wound healing
secondary to peripheral vascular disease, complications in such a category would be observed in
greater numbers in patients with diabetes.

Given that our study exhibits large numbers of hospital admissions due to cardiovascular causes,
peripheral vascular disease complications and dialysis vascular access complications; such
admissions can be truncated given our focus of prevention of diabetic complications. It is well
established that patients with diabetes or cardiovascular disease incur higher cost compared to
those who have no diabetes or cardiovascular disease, respectively. If we screen for
complications of peripheral vascular disease such as ulcers, decreased peripheral circulation and
wound healing, etc. during frequent dialysis appointments, we may dramatically curtail the
number of admissions and duration of stay due to these ailments.
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Our results do however have limitations. Duration of stay maybe skewed based one patient’s
prolonged hospitalization in a single admission, this maybe the cause of no statistically
significant difference between hospitalizations due to infectious disease. Furthermore, we did
not include modality of dialysis used, hemodialysis or peritoneal dialysis, at onset of renal failure
in our study. Murphy and colleagues have exhibited an increase in hospital admissions in
patients treated with peritoneal dialysis compared with hemodialysis (15). Similarly, number of
admissions has been correlated to time period status post dialysis onset; 3 months after initiation
of dialysis exhibiting the majority of hospital admissions (1). Future goals of our study are to
include date of onset of dialysis, thereby evaluating the pre and post dialysis period, cause
specific hospital admissions and duration, and rate calculation (number of hospital admissions
per patient month and year at risk). We intend to investigate various pre and post dialysis
durations with respect to cause specific etiologies of presentation in both non-diabetic and
diabetic populations.

10

REFERENCES
1.

Arora P, et al. Hospital utilization among chronic hemodialysis patients. J Am Soc
Nephrol 2000; 11: 740-746

2.

US Renal Data System, USRDS 2004 Annual data Report: Atlas of End-Stage Renal
Disease in the United States, National Institutes of Health, National Institute of Diabetes
and Digestive and Kidney Diseases, Bethesda, MD 2004: pp117-138.

3.

Ifudu O, et al. Correlates of vascular access and nonvascular access-related
hospitalizations in hemodialysis patients. Am J Nephrol 1996; 16: 118-23.

4.

Rocco MV, et al Utilization of inpatient and outpatient resources for the management of
hemodialysis access complications. Am J Kidney Dis 1996; 28: 250-6.

5.

Adeniyi OA, Tzamaloukas AH. Relation between access-related infections and preinfection serum albumin concentration in patients on chronic hemodialysis. Hemodial Int
2003; 7: 304-310.

6.

Goncalves EA, et al. Effect of temporary catheter and late referral on hospitalization and
mortality during the first year of hemodialysis treatment. Artif Organs 2004; 28: 1043-9.

7.

Churchill DN, et al. Effect of recombinant human erythropoietin on hospitalization of
hemodialysis patients. Clin Nephrol 1995; 43: 184-8.

8.

Habach G, et al. Hospitalization among United States dialysis patients: hemodialysis
versus peritoneal dialysis. J Am Soc Nephrol 1995; 5: 190-8.

9.

Strawderman RL, et al. Using USRDS generated hospitalization tables to compare local;
dialysis patient hospitalization rates to national rates. Kidney Int 1996; 50: 571-8.

11

10.

Feldman HI, et al. Association of dialyzer reuse and hospitalization rates among
hemodialysis patients in the US. Am J Nephrol 1999; 19: 641-8.

11.

Becker BN, et al. Risk factors for hospitalization in well-dialyzed chronic hemodialysis
patients. Am J Nephrol 1999; 19: 565-70.

12.

Ikizler TA, et al. Association of morbidity with markers of nutrition and inflammation in
chronic hemodialysis patients. Kidney Int 1999; 55: 1945-51.

13.

Xia H, et al. Hematocrit levels and hospitalization risks in hemodialysis patients. J Am
Soc Nephrol 1999; 10: 1309-16.

14.

Hospitalization in ESRD. Am J Kidney Dis 1999; 34, 2 Suppl. 1: S114-23.

15.

Murphy SW, et al. Comparative hospitalization of hemodialysis and peritoneal dialysis
patients in Canada. Kidney Int 2000; 57: 2557-63.

16.

Baugh ME, et al. Are lipid values and BMI related to hospitalizations in the
hemodialysis population? J Ren Nutr 2001; 11: 37-45.

17.

Collins AJ, et al. Death, hospitalization and economic associations among incident
hemodialysis patients with hematocrit values of 36% to 39%. J Am Soc Nephrol 2001;
12: 2465-73.

18.

Abbott KC, et al. Hospitalizations for fungal infections after initiation of chronic dialysis
in the United States. Nephron 2001; 89: 426-32.

19.

Abbott KC, et al. Hospitalizations for bacterial septicemia in patients with end stage
renal disease due to diabetes on the renal transplant waiting list. J Nephrol 2002; 15:
248-54.

12

20.

Abbott KC, et al. Hospitalizations for bacterial endocarditis after initiation of chronic
dialysis in the United States. Nephron 2002; 91: 203-9.

21.

Abbott KC, et al. Hospitalizations for valvular heart disease in chronic dialysis patients
in the United States. Nephron 2002; 92: 43-50.

22.

Abbott KC, et al. Atrial fibrillation in chronic dialysis patients in the United States: risk
factors for hospitalization and mortality. BMC Nephrol 2003; 4: 1.

23.

Brattich M, et al. Relationships between hemoglobin and hematocrit levels and
hospitalization and survival rates in dialysis patients. Nephrol Nurs J 2003; 30: 231-4.

24.

Oftshun N, et al. The effects of higher hemoglobin levels on mortality and
hospitalization in hemodialysis patients. Kidney Int 2003; 63: 1908-14.

25.

Lowrie EG, et al. Medical outcomes study short form-36: a consistent and powerful
predictor of morbidity and mortality in dialysis patients. Am J Kidney Dis 2003; 41:
1286-92.

26.

Trespalacios FC, et al. Heart failure as a cause for hospitalization in chronic dialysis
patients. Am J Kidney Dis 2003; 41: 1267-77.

27.

Pipim LB, et al. The extent of uremic malnutrition at the time of initiation of
maintenance hemodialysis is associated with subsequent hospitalization. J Ren Nutr
2003; 13: 259-66.

28.

Mix TC, et al. Hospitalization during advancing chronic kidney disease. Am J Kidney
Dis 2003; 42: 972-81.

13

29.

Rayner HC, et al. Mortality and hospitalization in hemodialysis patients in five European
countries: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Nephrol Dial Transplant 2004; 19: 108-20.

30.

Di Iorio B, et al. Charlson Comorbidity Index is a predictor of outcomes in incident
hemodialysis patients and correlates with phase angle and hospitalization. Int J Artif
Organs 2004; 27: 330-6.

31.

Di Napoli A, et al. Determinants of hospitalization in a cohort of chronic dialysis
patients in central Italy. J Nephrol 2005; 18: 21-9.

32.

Saad E, Servilla KS, Tzamaloukas AH. Hospitalizations in prevalent patients on chronic
hemodialysis. Hemodialysis Int 2003; 7: 84-85.

33.

Carlson DM, Duncun DA, Naessens JM, et al. Hospitalization in dialysis patients. Mayo
Clin Proc 1984; 59: 769-775

34.

Jones KR. Factors associated with hospitalization in a sample of chronic hemodialysis
patients. Health Service Research 1991; 26: 671-699

35.

Rocco MV, Soucie MJ, Reboussin DM, et al. Rick factors for hospital utilization in
chronic dialysis patients. J Am Soc Nephrol 1996; 889-896

36.

Khan SS, Kazmi WH, Abichandani R, et al. Health care utilization among patients with
chronic kidney disease. Kidney Int. 2002; Jul;62(1):229-36.

14

Table 1. Patient demographics and overall hospitalization characteristics
Characteristic

Age (years)
Women
Hospitalization Days
Number of Admissions
Inpatient Day Rates

Diabetic
(N=146)

Non-Diabetic
(N=98)

64
6
9595
871
10.99

63
4
5326
602
8.85
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Table 2. Cause specific hospitalization days and days per admission
Characteristic

Diabetic
(N=146)

Non-Diabetic
(N=98)

Hospitalization Days
Group 1
Group 2
Group 3
Group 4
Group 5

2677
1900
364
3569
1085

1225
1081
389
2526
105

Days per Admission
Group 1
Group 2
Group 3
Group 4
Group 5

13.52
10.38
5.78
10.00
15.07

9.65
6.76
6.17
10.48
9.55
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Table 3. Cause specific number of admissions with p-values
Characteristic

Number of Admissions
Group 1
Group 2
Group 3
Group 4
Group 5

Diabetic
(N=146)

197
183
63
356
72

Non-Diabetic
(N=98)

127
160
63
241
11

p-value

0.522
<0.05
<0.05
0.787
<0.001
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Figure 1. Number of admissions per group in non-diabetics and diabetics
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Figure 2. Number of hospitalization days per group
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